{"id":801173,"date":"2026-04-09T12:24:02","date_gmt":"2026-04-09T12:24:02","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=801173"},"modified":"2026-04-09T12:24:02","modified_gmt":"2026-04-09T12:24:02","slug":"hemostats-market-to-reach-400-billion-by-2030","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/hemostats-market-to-reach-400-billion-by-2030_801173.html","title":{"rendered":"Hemostats Market to Reach $4.00 Billion by 2030"},"content":{"rendered":"<div style=\"float:right;  width:250px; padding:8px 10px 10px 10px;\"><a href=\"https:\/\/www.abnewswire.com\/upload\/2026\/04\/1775735266.jpg\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"Hemostats Market to Reach $4.00 Billion by 2030\" src=\"https:\/\/www.abnewswire.com\/upload\/2026\/04\/1775735266.jpg\" alt=\"Hemostats Market to Reach $4.00 Billion by 2030\" width=\"225\" height=\"225\" \/><\/a><\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">Hemostats Market by Type (Thrombin, Combination, Gelatin, Collagen), Formulation (Matrix &#038; Gel, Sheet &#038; Pad, Sponge, Powder), Application (Orthopedic, General, Cardiovascular), End User (Hospital, Specialty Clinic), Region &#8211; Global Forecast to 2030<\/div>\n<p style=\"text-align: justify;\">According to the latest research by MarketsandMarkets&trade;, the global <strong><a rel=\"nofollow\" href=\"https:\/\/www.marketsandmarkets.com\/Market-Reports\/hemostats-market-9571619.html?utm_source=abnewswire.com&amp;utm_medium=referral&amp;utm_campaign=paidpr\">Hemostats Market<\/a><\/strong> is poised for steady growth, projected to reach <strong>USD 4.00 billion by 2030<\/strong>, up from <strong>USD 2.90 billion in 2025<\/strong>, registering a <strong>CAGR of 6.4%<\/strong> during the forecast period. This growth trajectory is driven by the rapid expansion of surgical infrastructure, increasing procedure volumes, and a growing emphasis on improving surgical outcomes.<\/p>\n<p style=\"text-align: justify;\">The rising number of hospitals and ambulatory surgical centers worldwide is significantly accelerating demand for advanced hemostatic solutions. The increasing incidence of trauma cases and emergency procedures has further intensified the need for efficient bleeding control technologies, making hemostats a critical component in modern surgical protocols.<\/p>\n<p style=\"text-align: justify;\"><strong>Download PDF Brochure: <a rel=\"nofollow\" name=\"www_marketsandmarkets_com_pdfdownlo\" href=\"https:\/\/www.marketsandmarkets.com\/pdfdownloadNew.asp?id=9571619&amp;utm_source=abnewswire.com&amp;utm_medium=referral&amp;utm_campaign=paidpr\">https:\/\/www.marketsandmarkets.com\/pdfdownloadNew.asp?id=9571619<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Browse<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li><strong>230 <\/strong>Market Data Tables<\/li>\n<li><strong>60 <\/strong>Figures<\/li>\n<li><strong>261 <\/strong>Pages and in-depth TOC on<strong> &#8220;<\/strong> <strong>Hemostats Market<\/strong> <strong><strong>&#8211; Global Forecast to 2030&rdquo;.<\/strong><\/strong><\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Market Dynamics Driving Growth<\/strong><\/p>\n<p style=\"text-align: justify;\">The market is witnessing strong momentum due to the continuous expansion of healthcare infrastructure across both developed and emerging economies. With rising patient volumes and surgical interventions, healthcare providers are prioritizing the adoption of reliable and efficient hemostatic agents to minimize intraoperative blood loss and improve patient safety. Additionally, advancements in surgical techniques, including minimally invasive procedures, are creating new avenues for innovation in hemostatic product development.<\/p>\n<p style=\"text-align: justify;\"><strong>Segment Insights<\/strong><\/p>\n<p style=\"text-align: justify;\">By type, <strong>oxidized regenerated cellulose (ORC)-based hemostats<\/strong> accounted for the largest market share in 2024. Their bioabsorbable nature, antimicrobial properties, and proven efficacy across multiple surgical disciplines make them a preferred choice among clinicians. These products eliminate the need for removal after surgery, reducing complications and enhancing recovery outcomes.<\/p>\n<p style=\"text-align: justify;\">By formulation, <strong>matrix &amp; gel hemostats<\/strong> dominated the market in 2024 due to their versatility and ease of application. Their ability to conform to complex anatomical structures and effectively manage various bleeding intensities makes them highly suitable for both open and minimally invasive procedures.<\/p>\n<p style=\"text-align: justify;\">In terms of application, the <strong>reconstructive surgery segment<\/strong> is expected to register the highest growth rate during the forecast period. The surge in aesthetic procedures, trauma-related surgeries, and post-cancer reconstructive treatments is significantly driving demand in this segment.<\/p>\n<p style=\"text-align: justify;\"><strong>End User &amp; Regional Outlook<\/strong><\/p>\n<p style=\"text-align: justify;\">Hospitals continue to be the largest end users of hemostatic products, driven by high surgical volumes, access to advanced technologies, and the presence of specialized surgical expertise. Their role as early adopters of innovative solutions further strengthens their dominance in the market.<\/p>\n<p style=\"text-align: justify;\">Regionally, <strong>North America<\/strong> led the global hemostats market in 2024, supported by advanced healthcare systems, high surgical procedure rates, and strong adoption of innovative medical technologies. Meanwhile, emerging markets are expected to present lucrative growth opportunities due to improving healthcare infrastructure and increasing access to surgical care.<\/p>\n<p style=\"text-align: justify;\"><strong>Request Sample Pages: <a rel=\"nofollow\" href=\"https:\/\/www.marketsandmarkets.com\/requestsampleNew.asp?id=9571619&amp;utm_source=abnewswire.com&amp;utm_medium=referral&amp;utm_campaign=paidpr\">https:\/\/www.marketsandmarkets.com\/requestsampleNew.asp?id=9571619<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Competitive Landscape<\/strong><\/p>\n<p style=\"text-align: justify;\">The global hemostats market is highly competitive, with key players focusing on strategic initiatives such as product launches, partnerships, acquisitions, and geographic expansion to strengthen their market presence. Leading companies include Johnson &amp; Johnson Services, Inc., Baxter, Pfizer Inc., B. Braun SE, BD, Teleflex Incorporated, Medtronic, Stryker, Integra LifeSciences, and Advanced Medical Solutions Group plc, among others.<\/p>\n<p style=\"text-align: justify;\">As surgical demand continues to rise globally, the hemostats market is expected to witness sustained growth, driven by innovation, increasing healthcare investments, and the ongoing need for effective bleeding management solutions.<\/p>\n<p style=\"text-align: justify;\"><strong>Related Reports:<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong><a rel=\"nofollow\" href=\"https:\/\/www.marketsandmarkets.com\/pdfdownloadNew.asp?id=703&amp;utm_source=abnewswire.com&amp;utm_medium=referral&amp;utm_campaign=paidpr\">In Vitro Diagnostics Market<\/a> &#8211; Global Forecast to 2030<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong><a rel=\"nofollow\" href=\"https:\/\/www.marketsandmarkets.com\/pdfdownloadNew.asp?id=116764589&amp;utm_source=abnewswire.com&amp;utm_medium=referral&amp;utm_campaign=paidpr\">Infectious Disease Diagnostics Market<\/a>&#8211; Global Forecast to 2030<\/strong><\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/marketsandmarkets.com_145966.html\" rel=\"nofollow\">MarketsandMarkets\u2122 Research Private Ltd.<\/a><br \/><strong>Contact Person:<\/strong> Mr. Rohan Salgarkar<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=hemostats-market-to-reach-400-billion-by-2030\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> 18886006441<br \/><strong>Address:<\/strong>1615 South Congress Ave.  Suite 103, Delray Beach, FL 33445<br \/><strong>City:<\/strong> Florida<br \/><strong>State:<\/strong> Florida<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"https:\/\/www.marketsandmarkets.com\/Market-Reports\/hemostats-market-9571619.html\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.marketsandmarkets.com\/Market-Reports\/hemostats-market-9571619.html<\/a><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=hemostats-market-to-reach-400-billion-by-2030\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Hemostats Market by Type (Thrombin, Combination, Gelatin, Collagen), Formulation (Matrix &#038; Gel, Sheet &#038; Pad, Sponge, Powder), Application (Orthopedic, General, Cardiovascular), End User (Hospital, Specialty Clinic), Region &#8211; Global Forecast to 2030 According to the latest research by MarketsandMarkets&trade;, the &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/hemostats-market-to-reach-400-billion-by-2030_801173.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,405,406,411,404],"tags":[],"class_list":["post-801173","post","type-post","status-publish","format-standard","hentry","category-Business","category-Health-Medicine","category-Pharmaceuticals-Biotech","category-Technology","category-US"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/801173","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=801173"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/801173\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=801173"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=801173"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=801173"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}